2m 2m 2m 2m 2m 2m 2m
BIODESIX (BDSX)
NASDAQ
$21.87+$0.45 (+2.08%)
Price as of Jul 14, 2026 10:13 AM EDT- $221.8MMarket Cap
- 242.50%1-Year Change
- Diagnostics & ResearchIndustry
BIODESIX (BDSX)
$21.87+$0.45 (+2.08%)
BDSX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.42 | ||
Change | $0.00 (0.00%) | ||
Open | $21.40 | ||
High | $22.37 | ||
Low | $20.98 | ||
Previous Close | $21.42 | ||
Volume | 60,342 | ||
30-Day Average Volume | 104,046 | ||
1-Week Change | -1.97% | ||
1-Month Change | 42.23% | ||
1-Year Change | 242.50% | ||
3-Year Change | -7.67% | ||
5-Year Change | -91.14% | ||
Fundamentals | |||
Shares Outstanding | 10.4M | ||
Total Assets | $94.6M | ||
Market Cap | $221.8M | ||
Enterprise Value | $242.7M | ||
Period: QTR TTM FY | |||
Revenue | $25.6M | ||
Net Income | -$7.8M | ||
Free Cash Flow | -$10.2M | ||
EBIT | -$5.8M | ||
EBITDA | -$4.4M | ||
Net Working Capital | $26.4M | ||
EPS | -$0.81 | ||
Enterprise Value/EBITDA | -55 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 24 | ||
P/E | -26 | ||
PEG | 0 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/15/2025 | ||
Earnings & Revenue